Balang, Samera .

HRN: 24-53-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/11/2026
05/11/2026
IV
4.5gms
Loading Dose
DM FOOT
Checking Initial Appropriateness 
05/11/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/11/2026
05/17/2026
IV
2.25gm
Q6h
DM FOOT
Checking Initial Appropriateness 
05/11/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/11/2026
05/11/2026
IV
600mg
Q8h
DM Foot
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: